CAS 100442-88-4

Fórmula: C27H31ClFNO8

InChI: InChI=1S/C27H31ClFNO8/c28-18-7-5-17(6-8-18)27(38-26-23(34)21(32)22(33)24(37-26)25(35)36)11-14-30(15-12-27)13-1-2-20(31)16-3-9-19(29)10-4-16/h3-10,21-24,26,32-34H,1-2,11-15H2,(H,35,36)/t21-,22-,23+,24-,26-/m0/s1

Clave InChI: ZFNLYKVTHNLKNZ-AMWBNRJOSA-N

SMILES: C1CN(CCC1(C2=CC=C(C=C2)Cl)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)C(=O)O)O)O)O)CCCC(=O)C4=CC=C(C=C4)F

Haloperidol Glucuronide

CAS: 100442-88-4

Fórmula: C₂₇H₃₁ClFNO₈

Peso molecular: 551.99

Ref: 4Z-H-017

Haloperidol D-glucuronide

CAS: 100442-88-4

Fórmula: C₂₇H₃₁ClFNO₈

Pureza: ≥ 95.0%

Forma y color: White powder

Peso molecular: 552.0

Ref: 7W-GC9128

Haloperidol b-D-glucuronide

Producto controlado

CAS: 100442-88-4

Haloperidol b-D-glucuronide is the glucuronide conjugate of haloperidol. It is a major metabolite of haloperidol, which can be detected in urine samples and plasma concentration–time curves. It has been shown to be effective in the treatment of schizophrenic patients and is used as a marker for schizophrenia. Haloperidol b-D-glucuronide has been found to inhibit the reduction of carbonyl groups by human liver microsomes, but not rat liver microsomes. This inhibition may be due to its capacity to bind with human liver enzymes, such as cytochrome P450 reductase and glutathione reductase. Haloperidol b-D-glucuronide also inhibits the uptake of antipsychotic medications into human liver cells, but not rat liver cells.

Fórmula: C₂₇H₃₁ClFNO₈

Pureza: Min. 95%

Peso molecular: 551.99 g/mol

Ref: 3D-MH10160

Haloperidol Glucuronide

CAS: 100442-88-4

Fórmula: C₂₇H₃₁ClFNO₈

Peso molecular: 552

Ref: ST-EA-CP-H1038